We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close


  • April 6, 2015

    Haynes And Boone Ducks Legal Mal Suit Over Arbitration Bill

    Haynes and Boone LLP escaped a malpractice suit over nearly $200,000 in disputed consulting fees stemming from a client’s arbitration fight with a fabric retailer, when a Massachusetts federal judge ruled Friday that a choice of jurisdiction clause did not apply to the firm.

  • April 3, 2015

    Liberty Mutual's SLAPP Defense Fails In Unfair-Practices Suit

    A Massachusetts appeals court on Thursday upheld a lower court’s refusal to toss an unfair-settlement practices suit against Liberty Mutual Insurance Inc., saying that allowing the insurer to invoke the state's anti-Strategic Lawsuit Against Public Participation law to dismiss a complaint would gut the consumer protections in the statute.

  • April 3, 2015

    Class Says FDA Ruling Backs Nexium Pay-For-Delay Retrial

    On the heels of losing a pay-for-delay trial against Ranbaxy Pharmaceuticals Inc. and AstraZeneca PLC over generic Nexium, class plaintiffs contended Thursday that a recent U.S. Food and Drug Administration decision and other developments back their retrial request.

  • April 3, 2015

    Texas Roadhouse Discovery Bid Denied In EEOC Ageism Suit

    Texas Roadhouse Inc. lost its bid to compel records from the Equal Employment Opportunity Commission on Thursday when the Massachusetts federal judge overseeing the EEOC's age discrimination case against it ruled the records at issue were irrelevant and the request was too burdensome.

  • April 3, 2015

    Painkiller Developer Collegium Pharmaceutical Eyes $86M IPO

    Venture capital-backed Collegium Pharmaceutical Inc., a biotech developing a portfolio of abuse-deterrent drugs to treat chronic pain, on Thursday filed for an initial public offering that would raise $86.3 million, largely to fund its lead product candidate that the company hopes will challenge market-leading painkiller OxyContin.

  • April 2, 2015

    Teva Strikes $24M Deal To Exit Nexium Pay-For-Delay Suit

    Class action plaintiffs in a pay-for-delay case over generic versions of AstraZeneca PLC’s heartburn drug Nexium disclosed on Thursday a $24 million settlement freeing Teva Pharmaceutical Industries Ltd. from the case, according to filings in Massachusetts federal court.

  • April 2, 2015

    1st Circ. Urged To Rehear Bankruptcy Tax Debt Ruling

    A group of debtors who filed late tax returns urged the First Circuit on Wednesday to rethink a ruling that they couldn’t discharge tax debt owed to the Massachusetts Department of Revenue.

  • April 2, 2015

    Heated Carnival Co. Wage Row Sent To Mediation

    A Massachusetts federal judge on Wednesday ordered mediation for a class action brought by workers accusing a major New England carnival company of underpaying them and forcing them to pick up H-2B visa expenses.

  • April 1, 2015

    Sarepta Therapeutics Securities Class Action Gets The Boot

    A Massachusetts federal judge on Tuesday tossed a proposed putative securities class action accusing Sarepta Therapeutics Inc. of misleading investors over the chances of its muscular dystrophy drug eteplirsen hitting the market, saying that the biopharma company couched its optimistic statements with proper disclosures.

  • April 1, 2015

    Universal Health Rips 1st Circ. Over FCA Suit Revival

    Universal Health Services Inc. is accusing the First Circuit of improperly reviving a False Claims Act complaint by unilaterally identifying regulations that whistleblowers never discussed and then misconstruing those regulations to suggest Medicaid fraud may have occurred, newly filed documents show.

  • April 1, 2015

    Sidley Austin Adds 5th Cadwalader Atty To Energy Team

    Sidley Austin LLP has announced the hiring of a former Cadwalader Wickersham & Taft LLP partner with expertise in energy regulatory issues to its Boston office.

  • April 1, 2015

    TerraForm Pays $350M For Atlantic Power Wind Farms

    TerraForm Power Inc., the yieldco of clean energy developer SunEdison Inc., said Wednesday that it’s agreed to buy five wind farms from Atlantic Power Corp. for $350 million, a day after it paid $110 million for a slate of solar projects developed by its corporate parent.

  • March 31, 2015

    Chipotle Can't Escape EEOC's Disability Bias Claim

    A Massachusetts federal judge on Monday rejected a bid by the U.S. Equal Employment Opportunity Commission to obtain sanctions against Chipotle Mexican Grill Inc. over destroyed evidence in a disability discrimination case, but he also rejected the chain eatery's bid to have the case tossed. 

  • March 31, 2015

    Carnival Co. Bashes Worker Cert. Order In Visa, Wage Row

    A carnival company accused of underpaying employees and forcing them to pay visa expenses took issue with the workers’ proposed order for class certification Monday, saying their demands far exceed what was discussed in court.

  • March 31, 2015

    Ranbaxy, AstraZeneca Say Plaintiffs Lack Basis For New Trial

    Ranbaxy Inc. and AstraZeneca PLC urged a Massachusetts federal court Monday to deny a bid by plaintiffs who lost a recent pay-for-delay class action trial over the heartburn drug Nexium to file a supplemental submission, saying it provided no basis for a new trial.

  • March 31, 2015

    Ocean Spray Wins Delay On Cranberry Growers' Class Cert Bid

    A Massachusetts federal judge on Monday denied Ocean Spray Cranberries Inc.’s request to postpone ruling on a summary judgment motion filed by cranberry growers, but granted its bid to hold off on ruling on the growers’ class certification motion for the time being.

  • March 27, 2015

    Ocean Spray Wants Growers’ 'Irresponsible' Cert. Bid Paused

    Ocean Spray Cranberries Inc. asked a Massachusetts federal judge Friday to hold off on ruling on a class certification bid by the cranberry growers who brought the case until first determining whether they in fact have a viable antitrust claim, accusing the growers of “irresponsible” litigation tactics.

  • March 26, 2015

    UBS Settles With Client In Row Over $109M In Toxic MBS

    UBS Americas Inc. has agreed to a confidential settlement to end a lawsuit brought by Capital Ventures International alleging UBS subsidiaries sold it more than $109 million worth of risky mortgage-backed securities by billing them as safe investments, according to a stipulation filed Thursday.

  • March 26, 2015

    Flagship Ventures Raises $537M For Health-Focused Fund

    Health care- and sustainability-focused investor Flagship Ventures said Thursday it raised $537 million for its fifth fund, the largest for the firm and first in more than three years, nearly doubling its previous fund.

  • March 26, 2015

    1st Circ. Backs Rwandan Genocide Sisters' Convictions

    The First Circuit on Wednesday upheld the criminal convictions of two Rwandan sisters who, to gain entry into the U.S., lied to U.S. immigration officials about their ties to — and one sister's participation in — the mass killings that ravaged the Central African nation in the 1990s.